Jin-dan Wu

472 total citations
29 papers, 372 citations indexed

About

Jin-dan Wu is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Jin-dan Wu has authored 29 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Jin-dan Wu's work include Diabetes Management and Research (19 papers), Diabetes Treatment and Management (13 papers) and Metabolism, Diabetes, and Cancer (7 papers). Jin-dan Wu is often cited by papers focused on Diabetes Management and Research (19 papers), Diabetes Treatment and Management (13 papers) and Metabolism, Diabetes, and Cancer (7 papers). Jin-dan Wu collaborates with scholars based in China, Singapore and United States. Jin-dan Wu's co-authors include Jianhua Ma, Lei Ye, Feng-fei Li, Xiaofei Su, Xiaohua Xu, Xiao‐Ming Mao, Kok‐Onn Lee, Liyuan Fu, Jian Zhu and Bo Ding and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Medicine.

In The Last Decade

Jin-dan Wu

28 papers receiving 366 citations

Peers

Jin-dan Wu
H. Katz United States
Phillip Williams United States
Marta Schnitman Argentina
Lily Agrawal United States
Jin-dan Wu
Citations per year, relative to Jin-dan Wu Jin-dan Wu (= 1×) peers Atsushi Fukao

Countries citing papers authored by Jin-dan Wu

Since Specialization
Citations

This map shows the geographic impact of Jin-dan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin-dan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin-dan Wu more than expected).

Fields of papers citing papers by Jin-dan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin-dan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin-dan Wu. The network helps show where Jin-dan Wu may publish in the future.

Co-authorship network of co-authors of Jin-dan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jin-dan Wu. A scholar is included among the top collaborators of Jin-dan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin-dan Wu. Jin-dan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Shuai, Jin-dan Wu, Xiaomei Liu, et al.. (2023). Altered resting-state brain activity in major depressive disorder comorbid with subclinical hypothyroidism: A regional homogeneity analysis. Brain Research Bulletin. 202. 110754–110754. 3 indexed citations
2.
Huang, Rong, Huiying Wang, Ziyang Shen, et al.. (2022). Increased Glycemic Variability Evaluated by Continuous Glucose Monitoring is Associated with Osteoporosis in Type 2 Diabetic Patients. Frontiers in Endocrinology. 13. 861131–861131. 11 indexed citations
4.
Huang, Rong, Tingting Cai, Yunting Zhou, et al.. (2021). Ethnicity Differences in the Association of UCP1‐3826A/G, UCP2‐866G/A and Ala55Val, and UCP3‐55C/T Polymorphisms with Type 2 Diabetes Mellitus Susceptibility: An Updated Meta‐Analysis. BioMed Research International. 2021(1). 3482879–3482879. 4 indexed citations
5.
Li, Feng-fei, Wenli Zhang, Wei Chen, et al.. (2018). Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy. Scientific Reports. 8(1). 5888–5888. 9 indexed citations
6.
Li, Feng-fei, Rengna Yan, Danfeng Zhang, et al.. (2018). Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes. Scientific Reports. 8(1). 9713–9713. 5 indexed citations
7.
Zhang, Qing, Peng Zhang, Rui Yan, et al.. (2018). A Single-Blinded Trial Using Resting-State Functional Magnetic Resonance Imaging of Brain Activity in Patients with Type 2 Diabetes and Painful Neuropathy. Diabetes Therapy. 10(1). 135–147. 24 indexed citations
8.
Li, Feng-fei, Honghong Zhu, Ting Li, et al.. (2017). Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men. Journal of Diabetes Research. 2017. 1–8. 13 indexed citations
9.
Li, Feng-fei, Rengna Yan, Honghong Zhu, et al.. (2017). Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values. Scientific Reports. 7(1). 1583–1583. 12 indexed citations
10.
Li, Feng-fei, Yun Shen, Rui Sun, et al.. (2017). Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes. Diabetes Therapy. 8(5). 1111–1122. 10 indexed citations
11.
Li, Feng-fei, Danfeng Zhang, Xiaofei Su, et al.. (2017). Young onset type 2 diabetic patients might be more sensitive to metformin compared to late onset type 2 diabetic patients. Scientific Reports. 7(1). 16382–16382. 8 indexed citations
12.
Li, Feng-fei, Liyuan Fu, Xiaofei Su, et al.. (2016). Analysis of the add-on effect of α-glucosidase inhibitor, acarbose in insulin therapy: A pilot study. Biomedical Reports. 5(4). 461–466. 11 indexed citations
13.
Wu, Jin-dan, Sha Tao, Xingzhong Jin, et al.. (2016). PGE1 improves diabetic peripheral neuropathy in patients with type 2 diabetes. Prostaglandins & Other Lipid Mediators. 126. 24–28. 5 indexed citations
14.
Li, Feng-fei, Lanlan Jiang, Rengna Yan, et al.. (2016). Effects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes. Medicine. 95(43). e5229–e5229. 12 indexed citations
15.
16.
Su, Xiaofei, Jin-dan Wu, Bo Ding, et al.. (2016). The Therapeutic Effect of Pancreatic Kininogenase on Treatment of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes. 124(10). 618–621. 3 indexed citations
17.
Li, Feng-fei, Xiaohua Xu, Liyuan Fu, et al.. (2015). Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study. International Journal of Endocrinology. 2015. 1–5. 24 indexed citations
18.
Su, Xiaofei, Liyuan Fu, Jin-dan Wu, et al.. (2011). Fulminant Type 1 Diabetes Mellitus: A Study of Nine Cases. Diabetes Technology & Therapeutics. 14(4). 325–329. 2 indexed citations
19.
Su, Xiaofei, Jin-dan Wu, Qian Li, et al.. (2010). Clinical features of 6 patients with fulminant type 1 diabetes mellitus. 2(5). 329–333.
20.
Mao, Xiao‐Ming, Huiqin Li, Qian Li, et al.. (2009). Prevention of Relapse of Graves’ Disease by Treatment with an Intrathyroid Injection of Dexamethasone. The Journal of Clinical Endocrinology & Metabolism. 94(12). 4984–4991. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026